OHSU. December 19, 2019
Dangerous bone marrow, organ transplant complication explained

May 8, 2019 - VGTI Adjunct Associate Professor, Dr. Aleksandra Sikora’s  research “Neisseria gonorrhoeae MlaA influences gonococcal virulence and membrane vesicle production”  has been recommended in F1000Prime as being of special significance in its field by F1000 Faculty Member David Stephens.

Portland, Ore. - Oregon Health & Science University was recently awarded $45,000 from M.J. Murdock Charitable Trust's Partners in Science program. The grants, at $15,000 each, will fund three different projects and give local high school teachers at the international school of Beaverton, Hillsboro High School and Madison High School the opportunity to engage in research with outstanding mentors at OHSU.

  • Rebecca Skalsky, assistant professor at OHSU's Vaccine and Gene Therapy Institute, and Brian Pendergrass, teacher at Hillsboro High School, to research validation of conserved Epstein-Barr virus microRNA targets involved in B-cell differentiation.

Vaccine Technology developed by OHSU scientists acquired by industry leaders, January 25, 2017 

1st Time Award Recipients as Faculty, Staff Scientists

Ben Burwitz’s, Staff Scientist new grant

February 11, 2015 - amfAR's Board of Trustees approved the first round of 11 innovation grants totaling close to $2 million. One of the new grants will support a study by Dr. Benjamin Burwitz of Oregon Health & Science University in Portland that could help determine the precise mechanism of action that led to the first and only known HIV cure in "the Berlin patient." The cure was the result of a stem cell transplant involving donated cells with a genetic mutation rendering them impervious to HIV infection. Dr. Burwitz and colleagues plan to generate a non-human primate model that will allow the testing of many hypotheses concerning the Berlin patient's cure, as well as, for example, gene therapy interventions designed to cure HIV.